B-Flexion Fund Management (Jersey)

B-Flexion Fund Management (Jersey)

B-Flexion Fund Management (Jersey) was established as a regulated investment entity in the Channel Islands, forming one piece of the broader B-Flexion group that oversees the investment affairs of the Bertarelli family. The wealth originates from Serono, the Swiss biotech company founded by Ernesto's father, which Merck acquired in what remains one of the largest cash transactions in European pharmaceutical history. Since that exit, the family has institutionalized its capital management through structures spanning Geneva, London, Luxembourg, and Jersey — with B-Flexion Fund Management acting as the regulated fund platform for certain pooled and managed vehicles. The firm deploys capital across a genuinely multi-asset mandate. Public disclosures and fund filings indicate positions spanning public equities, private equity, venture capital, and real assets. Within private markets, the focus leans toward life sciences and healthcare innovation — an area of demonstrable family expertise — alongside technology, consumer, and select infrastructure plays. The vehicle structure has historically included both direct co-investments alongside external managers and commitments to third-party funds, offering flexibility in how exposure to each sector is built. Scale remains opaque. Neither the AUM within the Jersey entity nor the broader Bertarelli family fortune is publicly disclosed. The Jersey Financial Services Commission regulates B-Flexion Fund Management (Jersey), which suggests a professionalized operation with third-party capital or pooled family vehicles rather than a pure single-family office. The group also maintains B-Flexion Advisory (Luxembourg) and the Waypoint Capital platform, indicating a multi-jurisdictional architecture typical of European family offices managing complex cross-border wealth. Structurally, what distinguishes the B-Flexion setup is the deliberate interplay between a Geneva-anchored family office, a London-based asset manager, and a Luxembourg advisory entity — creating a capital-deployment architecture that separates strategic asset allocation from fund structuring and regulatory oversight. This design, while not unique among large European family offices, reflects a governance approach where the Jersey entity serves as the regulated access point for external managers to receive family capital through institutional-grade fund vehicles.